- Sen. Manchin's opposition to BBB will cost the US roughly $60 billion in growth,
Goldman Sachs said. - On Monday, the bank lowered its forecasts for growth in the first three quarters of next year.
Sen.
What little hope Democrats had of passing their social-spending package evaporated on Sunday when the centrist West Virginia senator declared on Fox News that he wouldn't vote for the proposal in its current form. While Senate Democrats haven't completely thrown in the towel on passing another spending plan, Manchin's statement signals it will need to be dramatically different to garner his support.
Economists are already forecasting what a BBB-free
If the revisions ring true, the difference in growth should add up to roughly $60 billion in economic losses over the next three quarters. Insider calculated the sum by taking the US's annualized
The economic impact might not be so negative, the team noted. There's a chance Congress approves "a much smaller set of fiscal proposals" targeting manufacturing bottlenecks and supply-chain pressures, according to the economists.
Still, the most important element of BBB for
Many other Democrats, however, have fervently pushed against work requirements, leaving the tax credit to expire this month. Removing the CTC will lead to government aid in 2022 that's "somewhat more negative than we had expected," Goldman said. There's "still a chance" that Congress retroactively extends the program, but the odds of that are "less than even," the bank added.
The death of BBB might also throw a wrench in the Federal Reserve's plans to fight inflation, according to the team. Most central bank officials likely expected Congress to pass the spending package, and those assumptions probably showed up in the Fed's economic projections published last week. Failure to pass BBB "would introduce some risk" to Goldman's expectations for the Fed to raise interest rates in March and start cooling inflation, the team said.
The economic boom seen through the summer is suddenly on the ropes. The Omicron variant's rapid spread is quickly reviving some economic restrictions across the country, and early signs point to consumer spending already starting to ease. With BBB likely off the table, the US recovery is entering the new year with far less juice than economists anticipated just days ago.